Search research articles
Contact Us
Filters
Showing results (11-20 of 197) with videos related to
Page
of 20
Sort By:
Hospitals & Health Networks
|
May 25, 2013
Positive outcomes. It takes a village to reduce readmissions. Minnesota hospitals lock arms with others to tackle the problem
Lola Butcher
Hospitals & Health Networks
|
January 22, 2013
Value shopping. Paying set price wins over payers
Lola Butcher
Hospitals & Health Networks
|
January 22, 2013
Equal partners. Teaming up to keep patients out of the black hole
Lola Butcher
Hospitals & Health Networks
|
January 22, 2013
A different kind of medical home
Lola Butcher
Biotechnology Healthcare
|
January 16, 2013
Commercial formularies face pressure to go 4-tier
Lola Butcher
Biotechnology Healthcare
|
January 16, 2013
PA No More?
Lola Butcher
Biotechnology Healthcare
|
April 6, 2012
Solid tumors: prevalence, economics, and implications for payers and purchasers
Lola Butcher
Biotechnology Healthcare
|
April 6, 2012
What path do we take?
Lola Butcher
Biotechnology Healthcare
|
April 6, 2012
MS: Prevalence, Economics, and the Pipeline
Lola Butcher
Biotechnology Healthcare
|
April 6, 2012
Value-based insurance design
Lola Butcher
Page
of 20
Search research articles
Search
Showing results (11-20 of 197) with videos related to
Sort By:
Page
of 20
Hospitals & Health Networks
|
May 25, 2013
Positive outcomes. It takes a village to reduce readmissions. Minnesota hospitals lock arms with others to tackle the problem
Lola Butcher
Hospitals & Health Networks
|
January 22, 2013
Value shopping. Paying set price wins over payers
Lola Butcher
Hospitals & Health Networks
|
January 22, 2013
Equal partners. Teaming up to keep patients out of the black hole
Lola Butcher
Hospitals & Health Networks
|
January 22, 2013
A different kind of medical home
Lola Butcher
Biotechnology Healthcare
|
January 16, 2013
Commercial formularies face pressure to go 4-tier
Lola Butcher
Biotechnology Healthcare
|
January 16, 2013
PA No More?
Lola Butcher
Biotechnology Healthcare
|
April 6, 2012
Solid tumors: prevalence, economics, and implications for payers and purchasers
Lola Butcher
Biotechnology Healthcare
|
April 6, 2012
What path do we take?
Lola Butcher
Biotechnology Healthcare
|
April 6, 2012
MS: Prevalence, Economics, and the Pipeline
Lola Butcher
Biotechnology Healthcare
|
April 6, 2012
Value-based insurance design
Lola Butcher
Page
of 20